scholarly article | Q13442814 |
P356 | DOI | 10.1136/ARD.2008.089862 |
P698 | PubMed publication ID | 18701555 |
P2093 | author name string | J Fransen | |
R F J M Laan | |||
P L C M van Riel | |||
C Popa | |||
D A Popa-Diaconu | |||
A Eijsbouts | |||
B J Radovits | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
rheumatoid arthritis | Q187255 | ||
risk factor | Q1475848 | ||
P304 | page(s) | 1271-1276 | |
P577 | publication date | 2008-08-13 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis | |
P478 | volume | 68 |
Q33687843 | Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis |
Q54597679 | Adipocytokines in rheumatoid arthritis and obesity |
Q34495257 | Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america |
Q28390163 | Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis |
Q35617716 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study |
Q43832641 | Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? |
Q36245981 | High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study |
Q54060732 | Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. |
Q37156561 | Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis |
Q41628272 | Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta-Analysis of Cohort Studies |
Q24630655 | Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity |
Q36054251 | Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. |
Q41617609 | Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study |
Q57751622 | Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis |
Q41176187 | Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides |
Q41211836 | The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? |
Q49787347 | The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients |
Q43714093 | The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients |
Q37640953 | The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review |
Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
Q33892790 | The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study |
Q37808889 | Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review |
Q38249105 | Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes |
Search more.